MedPath

BENAMOUZIG ROBERT

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Pasireotide for the Treatment of Gastrointestinal Angiodysplasia in Endoscopic Treatment Failure

Phase 2
Completed
Conditions
Angiodysplasia
Interventions
Drug: Placebo
First Posted Date
2015-12-07
Last Posted Date
2015-12-07
Lead Sponsor
Robert Benamouzig
Target Recruit Count
24
Registration Number
NCT02622906
Locations
🇫🇷

Société Française d'Endoscopie Digestive (SFED), Paris, France

© Copyright 2025. All Rights Reserved by MedPath